Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
Clinical trial NCT02775916 · COMPLETED
Trial details
- NCT number
- NCT02775916
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-05-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.